Effects of 2-amino-4,6-dinitrotoluene on p53 tumor suppressor gene expression

Molecular and Cellular Biochemistry

Volumn 252, Issue 1-2, 2003, Pages 387-389

  Banerjee, Hirendra ^a   Hawkins, Zack ^a   Dutta, Sisir ^a   Smoot, Duane ^a  

^a ELIZABETH CITY STATE UNIVERSITY   (United States)

Author keywords

2 Am DNT; MCF7 cells; p53 protein; Tumor suppressor

Indexed keywords

2 AMINO 4,6 DINITROTOLUENE; DNA; MONOCLONAL ANTIBODY; PROTEIN P53; TOLUENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; BIOASSAY; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN DNA BINDING; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANILINE COMPOUNDS; BASE SEQUENCE; GENE EXPRESSION REGULATION; GENES, P53; OLIGONUCLEOTIDES;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0141728445     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025542429071     Document Type: Article

References (10)

1. Honeycutt ME, Jarvid AS, McFarland VA: Cytotoxicity and mutagenicity of 2,4,6-trinitrotoluene and its metabolites. Exotoxicol Environ Saf 35: 282-287, 1996
2. Lane DP, Crawford LV: T-antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261-263, 1979
3. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093, 1989
4. Dees C, Askari M, Henley D: Carcinogenic potential of benzene and toluene when evaluated using cyclin-dependent kinase activation and p53-DNA binding. Environ Health Perspect 104 (suppl 6): 1289-1292, 1996
5. Barnes DM, Hanby AM, Gillett CE, Mohammed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, MacGeoch C, Spurr NK: Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 340: 259-263, 1992
6. Banerjeee HN, Verma M, Hou LL, Ashaf M, Dutta SK: Cytotoxicity of TNT and its metabolites. Yale J Biol Med 72: 1-4, 1999
7. Dignam TD, Lebovitz RM, Reeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983
8. Dees C, Travis CC: Increased p53 site-specific DNA binding in cells producing mutant p53. Cancer Lett 96: 225-231, 1995
9. Lane DP, Stephen CW, Midgley CA, Sparks A, Hupp TR, Daniels DA, Greaves R, Reid A, Vojtesek B, Picksley SM: Epitope analysis of the murine p53 tumor suppressor protein. Oncogene 12: 2461-2466, 1996
10. Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. Embo J 9: 1595-1602, 1990